PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 52 filers reported holding PHOENIX BIOTECH ACQUISITION in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 163,538 | $1,746,586 | 0.12% |
| Q Global Advisors, LLC | 170,785 | $7 | 0.01% |
| MMCAP International Inc. SPC | 375,000 | $15,000 | 0.00% |
| Atalaya Capital Management LP | 225,000 | $9,000 | 0.00% |
| Sage Rock Capital Management LP | 91,999 | $3,689 | 0.00% |
| DIFESA CAPITAL MANAGEMENT, LP | 62,500 | $2,506 | 0.00% |
| Segantii Capital Management Ltd | 5,000 | $53,400 | 0.00% |
| PERISCOPE CAPITAL INC. | 957,098 | $38,301 | 0.00% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 577,844 | $14 | 0.00% |
| CVI Holdings, LLC | 65,227 | $3,261 | 0.00% |